These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 26972388

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Application of Static Modeling --in the Prediction of In Vivo Drug-Drug Interactions between Rivaroxaban and Antiarrhythmic Agents Based on In Vitro Inhibition Studies.
    Cheong EJ, Goh JJ, Hong Y, Venkatesan G, Liu Y, Chiu GN, Kojodjojo P, Chan EC.
    Drug Metab Dispos; 2017 Mar; 45(3):260-268. PubMed ID: 28053220
    [Abstract] [Full Text] [Related]

  • 4. Inactivation of Human Cytochrome P450 3A4 and 3A5 by Dronedarone and N-Desbutyl Dronedarone.
    Hong Y, Chia YM, Yeo RH, Venkatesan G, Koh SK, Chai CL, Zhou L, Kojodjojo P, Chan EC.
    Mol Pharmacol; 2016 Jan; 89(1):1-13. PubMed ID: 26490246
    [Abstract] [Full Text] [Related]

  • 5. Investigation of the arcane inhibition of human organic anion transporter 3 by benzofuran antiarrhythmic agents.
    Tan HL, Tang LWT, Chin SY, Chan ECY.
    Drug Metab Pharmacokinet; 2021 Jun; 38():100390. PubMed ID: 33836300
    [Abstract] [Full Text] [Related]

  • 6. Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
    Lee CA, Jones JP, Katayama J, Kaspera R, Jiang Y, Freiwald S, Smith E, Walker GS, Totah RA.
    Drug Metab Dispos; 2012 May; 40(5):943-51. PubMed ID: 22328583
    [Abstract] [Full Text] [Related]

  • 7. Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner.
    Lee E, Wu Z, Shon JC, Liu KH.
    Drug Metab Dispos; 2015 Aug; 43(8):1250-3. PubMed ID: 26048912
    [Abstract] [Full Text] [Related]

  • 8. Identification of novel substrates for human cytochrome P450 2J2.
    Lee CA, Neul D, Clouser-Roche A, Dalvie D, Wester MR, Jiang Y, Jones JP, Freiwald S, Zientek M, Totah RA.
    Drug Metab Dispos; 2010 Feb; 38(2):347-56. PubMed ID: 19923256
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory effects of antihypertensive drugs on human cytochrome P450 2J2 activity: Potent inhibition by azelnidipine and manidipine.
    Ikemura N, Yamaori S, Kobayashi C, Kamijo S, Murayama N, Yamazaki H, Ohmori S.
    Chem Biol Interact; 2019 Jun 01; 306():1-9. PubMed ID: 30965050
    [Abstract] [Full Text] [Related]

  • 10. Dronedarone-Induced Cardiac Mitochondrial Dysfunction and Its Mitigation by Epoxyeicosatrienoic Acids.
    Karkhanis A, Leow JWH, Hagen T, Chan ECY.
    Toxicol Sci; 2018 May 01; 163(1):79-91. PubMed ID: 29385569
    [Abstract] [Full Text] [Related]

  • 11. P450-Based Drug-Drug Interactions of Amiodarone and its Metabolites: Diversity of Inhibitory Mechanisms.
    McDonald MG, Au NT, Rettie AE.
    Drug Metab Dispos; 2015 Nov 01; 43(11):1661-9. PubMed ID: 26296708
    [Abstract] [Full Text] [Related]

  • 12. Heme Modification Contributes to the Mechanism-Based Inactivation of Human Cytochrome P450 2J2 by Two Terminal Acetylenic Compounds.
    Lin HL, Zhang H, Walker VJ, D'Agostino J, Hollenberg PF.
    Drug Metab Dispos; 2017 Sep 01; 45(9):990-999. PubMed ID: 28698302
    [Abstract] [Full Text] [Related]

  • 13. Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme.
    Lu J, Liu D, Zhou X, Chen A, Jiang Z, Ye X, Liu M, Wang X.
    Phytomedicine; 2018 Jan 15; 39():137-145. PubMed ID: 29433675
    [Abstract] [Full Text] [Related]

  • 14. LKY-047: First Selective Inhibitor of Cytochrome P450 2J2.
    Phuc NM, Wu Z, O Y, Lee JH, Oh S, Song GY, Liu KH.
    Drug Metab Dispos; 2017 Jul 15; 45(7):765-769. PubMed ID: 28461575
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions.
    Ohyama K, Nakajima M, Suzuki M, Shimada N, Yamazaki H, Yokoi T.
    Br J Clin Pharmacol; 2000 Mar 15; 49(3):244-53. PubMed ID: 10718780
    [Abstract] [Full Text] [Related]

  • 16. Activation of ALDH1A1 in MDA-MB-468 breast cancer cells that over-express CYP2J2 protects against paclitaxel-dependent cell death mediated by reactive oxygen species.
    Allison SE, Chen Y, Petrovic N, Zhang J, Bourget K, Mackenzie PI, Murray M.
    Biochem Pharmacol; 2017 Nov 01; 143():79-89. PubMed ID: 28756208
    [Abstract] [Full Text] [Related]

  • 17. Molecular determinant of substrate binding and specificity of cytochrome P450 2J2.
    Xu L, Chen LY.
    Sci Rep; 2020 Dec 17; 10(1):22267. PubMed ID: 33335233
    [Abstract] [Full Text] [Related]

  • 18. Identification of Infigratinib as a Potent Reversible Inhibitor and Mechanism-Based Inactivator of CYP2J2: Nascent Evidence for a Potential In Vivo Metabolic Drug-Drug Interaction with Rivaroxaban.
    Tang LWT, Wu G, Chan ECY.
    J Pharmacol Exp Ther; 2022 Aug 17; 382(2):123-134. PubMed ID: 35640957
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory Effects of Danshen components on CYP2C8 and CYP2J2.
    Xu MJ, Jiang LF, Wu T, Chu JH, Wei YD, Aa JY, Wang GJ, Hao HP, Ju WZ, Li P.
    Chem Biol Interact; 2018 Jun 01; 289():15-22. PubMed ID: 29689254
    [Abstract] [Full Text] [Related]

  • 20. Meclizine, a pregnane X receptor agonist, is a direct inhibitor and mechanism-based inactivator of human cytochrome P450 3A.
    Foo WY, Tay HY, Chan EC, Lau AJ.
    Biochem Pharmacol; 2015 Oct 01; 97(3):320-30. PubMed ID: 26239802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.